Thursday, April 22, 2010 2:45:16 PM
"Rumors of a lucrative buy-out or partnership have been swirling around the company during the past two weeks. Multiple sources told BioMedReports, that details about "a big announcement involving Positron and a much larger, publicly traded NYSE company worth at least $25 billion" could come as early as next Monday.
We reached out to Positron's Chariman of the Board, Patrick G. Rooney and the head of the small molecular imaging company focused on Nuclear Cardiology has confirmed that his company "is currently in discussions with a potential partner in our industry."
Rooney refused to offer any assurances or details about when an agreement might be reached. "
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM